Kathmere Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,139
| Closed | -$298K | – | 175 |
|
|
2022
Q2 | $298K | Buy |
3,139
+182
| +6% | +$17.3K | 0.05% | 124 |
|
|
2022
Q1 | $348K | Buy |
+2,957
| New | +$348K | 0.06% | 112 |
|
|
2021
Q4 | – | Sell |
-2,989
| Closed | -$338K | – | 145 |
|
|
2021
Q3 | $338K | Buy |
2,989
+109
| +4% | +$12.3K | 0.06% | 101 |
|
|
2021
Q2 | $298K | Hold |
2,880
| – | – | 0.06% | 110 |
|
|
2021
Q1 | $241K | Hold |
2,880
| – | – | 0.05% | 121 |
|
|
2020
Q4 | $263K | Buy |
2,880
+30
| +1% | +$2.74K | 0.06% | 102 |
|
|
2020
Q3 | $227K | Sell |
2,850
-1,992
| -41% | -$159K | 0.06% | 101 |
|
|
2020
Q2 | $335K | Buy |
+4,842
| New | +$335K | 0.1% | 75 |
|